ADIPOQ and atherosclerosis: Only 9 T1DM patients (17.3%) had adiponectin levels < 10 μg/mL, corresponding to medium severity risk for atherosclerosis and just one of these patients had adiponectin levels < 7 μg/mL, corresponding to high risk for atherosclerosis.